Treatment results of nasopharyngeal cancer. A nationwide survey from Finland

Acta Oncologica

Volumn 35, Issue 6, 1996, Pages 697-702

  Kajanti, Mikael ^a   Flander, Martti ^b   Grenman, Reidar ^c   Hietanen, Tenho ^d   Romppanen, Maija ^e   Turunen, Marita ^f   Valavaara, Ritva ^c   Joensuu, Heikki ^a  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^b SOUTH KARELIA CENTRAL HOSPITAL   (Finland)

^c TURKU UNIVERSITY HOSPITAL   (Finland)

^d TAMPERE UNIVERSITY HOSPITAL   (Finland)

^e OULU UNIVERSITY HOSPITAL   (Finland)

^f KUOPIO UNIVERSITY HOSPITAL   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

DISEASES; DRUG THERAPY; MATHEMATICAL MODELS; PATIENT MONITORING; RADIOTHERAPY;

BIOLOGICALLY EFFECTIVE DOSE; NASOPHARYNGEAL CANCER;

ONCOLOGY;

CISPLATIN; DOXORUBICIN; FLUOROURACIL;

ADULT; AGED; ARTICLE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NASOPHARYNX CANCER; PRIORITY JOURNAL;

EID: 0029959556     PISSN: 0284186X     EISSN: None     Source Type: Journal    
DOI: 10.3109/02841869609084001     Document Type: Article

References (24)

1. Bauer WC. Varieties of squamous carcinoma - Biologic behavior. Front Radiat Ther Oncol 1974; 9: 164-86.
2. Phyarnx, In: Hermanek P, Sobin LH, eds. TNM. Classification of malignant tumours. Fourth, fully revised version. Berlin, Heidelberg, New York, London, Paris, Tokyo: Springer-Verlag, 1987: 19-22.
3. Fowler JF. Review article - the linear quadratic formula and progress in fractionated radiotherapy. Br J Radiol 1989; 62: 199-207.
4. McGinn CJ, Harari PM, Fowler JF, Ford CN, Pyle GM, Kinsella TJ. Dose intensification in curative head and neck cancer - linear quadratic analysis and preliminary assessment of clinical results. Int J Radiat Oncol Biol Phys 1993; 27: 363-9.
5. Dixon MJ, editor. BMDP Statistical Software 1988. Berkeley, Los Angeles, London: University of California Press, 1988.
6. Chen KY, Fletcher GH. Malignant tumors of the nasopharynx. Radiology 1971; 99: 165-71.
7. Hoppe RT, Goffinet DR, Bagshaw MA. Carcinoma of the nasopharynx. Cancer 1976; 37: 260-12.
8. Wang CC, Meyer JE. Radiotherapeutic management of carcinoma of the nasopharynx. Cancer 1971; 28: 566-70.
9. Bedwinek JM, Perez CA, Keys DJ. Analyses of failures after definite irradiation for epidermoid carcinoma of the nasopharynx. Cancer 1980; 45: 2725-9.
10. Tokars RP, Griem ML. Carcinoma of the nasopharynx: An optimization of radiotherapeutic management for tumor control and spinal cord injury. Int J Radiat Oncol Biol Phys 1979; 5: 1741-8.
11. Chu AM, Flynn MB, Achino E, Mendoza EF, Scott RM, Jose B. Irradiation of nasopharyngeal cancer: correlations with treatment factors and stage. Int J Radiat Oncol Biol Phys 1984; 10: 2241-9.
12. Mesic JB, Fletcher GH, Goepfert H. Megavoltage irradiation of epithelial tumors of nasopharynx. Int J Radiat Oncol Biol Phys 1981; 7: 447-53.
13. Perez CA, Devineni VR, Marcial-Vega V, Marks JE, Simpson JR, Kucik N. Carcinoma of the nasopharynx: factors affecting prognosis. Int J Radiat Oncol Biol Phys 1992; 23: 271-80.
14. Kajanti MJ, Mäntylä MJ. Carcinoma of the nasopharynx. A retrospective analysis of treatment results in 125 patients. Acta Oncol 1990; 29: 611-4.
15. Zagars GK, Smith JL, Norante JD McDonald. Tumors of the head and neck. In: Rubin P, ed. Clinical oncology. A multidisciplinary approach for physicians and students. Philadelphia: W.B. Saunders Company, 1993: 319-62.
16. Shu-Chen H. Nasopharyngeal cancer: a review of 1 605 patients treated with cobalt-60. Int J Radiat Oncol Biol Phys 1980; 6: 401-7.
17. Ellis ER, Mendenhall WM, Rao PV, Parsons JT, Spangler AE, Million RR. Does node location affect the incidence of distant metastases in head and neck squamous cell carcinoma? Int J Radiat Oncol Biol Phys 1989; 17: 293-7.
18. Griffin TW, Pajak TF, Wilson Gillespie B, et al. Predicting the response of head and neck cancers to radiation therapy with a multivariate modelling system: an analysis of the RTOG head and neck cancer registry. Int J Radiat Oncol Biol Phys 1984; 10: 481-7.
19. Lee AWM, Chan DKK, Fowler JF, et al. Effect of time, dose and fractionation on local control of nasopharyngeal carcinoma. Radiother Oncol 1995; 36: 24-31.
20. Withers HR, Taylor JMG, Maciejewski B. The hazard of accelerated tumor clonogen repopulation during radiotherapy. Acta Oncol 1988; 27: 131-46.
21. Fazekas JT, Scott C, Marcial V, Davis LW, Wassermann T, Cooper JS, The role of hemoglobin concentration in the outcome of misonidazole-sensitized radiotherapy of head and neck cancers: based on RTOG trial No. 79-15. Int J Radiat Oncol Biol Phys 1989; 17: 1177-81.
22. del Regato JA, Spjut HJ, Cox JD. Nasopharynx. In: Ackerman & del Regato's Cancer. In: del Regato JA, Spjut HJ, Cox JD, eds. Diagnosis, Treatment & Prognosis. St. Louis, Toronto, Princeton: The C.V. Mosby Company, 1985: 310-28.
23. Al-Sarraf M, Pajak TF, Cooper JS, Mahiuddin M, Herskovic A, Ager PJ. Chemo-radiotherapy in patients with locally advanced nasopharyngeal carcinoma: a radiation therapy oncology group study. J Clin Oncol 1990; 8: 1342-51.
24. Dimery IW, Peters LJ, Goepfert H. Effectiveness of combined induction chemotherapy and radiotherapy in advanced nasopharyngeal carcinoma. J Clin Oncol 1993; 10: 1919-28.